Nexpoint Asset Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Nexpoint Asset Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25,000	Closed	-$83K	–	320
2019 Q4	$83K	Hold	25,000	–	–	0.01%	273
2019 Q3	$76K	Buy	+25,000	New	+$70.3K	﹤0.01%	313

Nexpoint Asset Management's FOMX Position: Q1 2020 in Review

Nexpoint Asset Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 25,000 shares — an estimated $83K sold.

Nexpoint Asset Management first reported a position in FOMX in Q3 2019 and held it in 2 quarters. The position peaked at $83K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Nexpoint Asset Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Nexpoint Asset Management sold 25,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $83K.
Nexpoint Asset Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2019 and held it in 2 quarters.
Nexpoint Asset Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $83K in Q4 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Nexpoint Asset Management's 13F filing for Q1 2020, filed 15 May 2020.